Scope
Scope Eyecare distributes preservative-free ophthalmic drops (HYLO, Hycosan), eyelid hygiene products (OPTASE), and nutritional supplements (Eyetamins) to patients and healthcare professionals across Ireland, the UK, and Channel Islands markets via e-commerce and pharmacy retail channels.
- Company typePrivate
- Founded2009
- HeadquartersDublin, Ireland
- Headcount51–100
- GTM type—
- OfferingHardware or Manufacturing
What Scope does
Scope Eyecare, operated by Scope Ophthalmics Ltd (with US parent Scope Health Inc.), is a Dublin-based eye care company founded in 2009 that distributes preservative-free ophthalmic products and nutritional supplements across Ireland, the United Kingdom, Guernsey, Isle of Man, and Jersey. The company sells four principal brand families: HYLO and Hycosan ranges of preservative-free lubricating eye drops delivered via the proprietary COMOD multi-dose system, which maintains 6-month sterility post-opening without chemical preservatives; OPTASE products for dry eye, Meibomian Gland Dysfunction (MGD), and blepharitis management including tea tree oil eyelid wipes and moist heat masks; and Eyetamins (acquired October 2024) which provides clinically-backed supplements such as AREDS2-based Vision Support and re-esterified triglyceride Omega-3 formulations. Underlying technology is rooted in formulation chemistry, particularly Sodium Hyaluronate at varying concentrations (0.03%-0.2%), Ectoin for tear film stabilization, and the patented COMOD bottle architecture that distinguishes Scope from conventional preserved-drop competitors.
The business operates a dual-channel go-to-market combining direct-to-consumer e-commerce at scopeeyecare.com (with free shipping over €25/£25) and third-party retail distribution through pharmacies and opticians across its served geographies, supplemented by healthcare professional (HCP) recommendation-driven pull-through. Revenue is generated through unit-pricing of consumable eye drops (€5.85-€19.95 per unit in Ireland) and supplements (€16.95-€34.95), with no subscription or recurring contract structure evidenced. Customer segments span individual dry eye disease patients, ophthalmologists/optometrists/pharmacists who dispense and recommend products, and pharmacy/optician retail buyers. Scope has held HYLO-Forte's 'Best Eye Care Product' title at the Irish Pharmacy News OTC & Retail Product Awards for three consecutive years (2022-2024) and reports 91% user recommendation for Eyetamins Vision Support, indicating strong brand traction within its regional OTC niche.
Scope firmographics
Firmographics- Name
- Scope
- Legal name
- Scope Ophthalmics Ltd
- Website
- https://scopeeyecare.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Scope Eyecare distributes preservative-free ophthalmic drops (HYLO, Hycosan), eyelid hygiene products (OPTASE), and nutritional supplements (Eyetamins) to patients and healthcare professionals across Ireland, the UK, and Channel Islands markets via e-commerce and pharmacy retail channels.
- Ownership category
- akta.pro rank
Scope industry classification
Industry- Product category
- Ophthalmic Eye Care Products
- NAICS
- Optical Goods Retailers (45613), Ophthalmic Goods Merchant Wholesalers (42346)
- SIC
- Ophthalmic Goods (3851)
- akta.pro primary industry
- Ocular Drug Delivery Devices (Eye Droppers/Inserts) (HLAHAIAL)
Keywords
Where Scope is headquartered
LocationHeadquarters
- HQ city
- Dublin
- HQ country
- Ireland
- HQ region
- Europe
Offices2 records
Markets served
Scope business model
Business model- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D, Others
Revenue model
- Eye Drop Product Sales: Direct e-commerce sales and retail distribution of preservative-free eye drops including HYLO, Hycosan, and Optase ranges. Products sold at various price points from €5.85 to €19.95 in Ireland/UK market.
- Eye Supplement Sales: Sales of Eyetamins branded nutritional supplements including Vision Support and OmegaEye Advanced for daily eye health maintenance.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | HYLO-Forte eye drops for severe dry eye symptoms |
| Unit Pricing | Pay-as-you-go | HYLO-Tear for mild to moderate dry eye |
| Unit Pricing | Pay-as-you-go | HYLO-Dual for lipid deficient dry eye and MGD |
| Unit Pricing | Pay-as-you-go | HYLO-Fresh for red, itchy eyes and screen fatigue |
| Unit Pricing | Pay-as-you-go | HYLO-Care for corneal repair |
| Unit Pricing | Pay-as-you-go | HYLO Night ointment for night-time relief |
| Unit Pricing | Pay-as-you-go | Eyetamins Vision Support supplement |
| Unit Pricing | Pay-as-you-go | Eyetamins OmegaEye Advanced Omega-3 supplement |
| Unit Pricing | Pay-as-you-go | Optase Tea Tree Oil Eyelid Wipes |
| Unit Pricing | Pay-as-you-go | Optase Moist Heat Mask |
| Unit Pricing | Pay-as-you-go | Standard shipping rate |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Scope product offering
Product offeringCore offering
Scope Eyecare (Scope Ophthalmics Ltd) distributes a portfolio of preservative-free eye care products including lubricant eye drops under the HYLO and Hycosan ranges, eyelid hygiene and thermal therapy products under the OPTASE brand, the EvoTears water-free lubricant, and the Eyetamins line of eye health nutritional supplements. The products target dry eye disease, meibomian gland dysfunction (MGD), blepharitis, ocular allergies, and macular support, delivered across Ireland and the UK through the company's own e-commerce storefront, pharmacies, and opticians.
Product overview
Scope Eyecare is an eye health company offering a comprehensive portfolio of preservative-free eye care products and nutritional supplements. The core product lines include the HYLO range (lubricating eye drops and ointments delivered via the proprietary COMOD system), the Hycosan range (preservative-free lubricants for various dry eye severities), and the Eyetamins brand (clinically-backed eye health supplements including lutein, zeaxanthin, and omega-3 formulations). Additional offerings include OPTASE thermal masks and eyelid hygiene products, and EvoTears for evaporative dry eye. The company acquired EYETAMINS in October 2024 and is rebranding its Actase supplement line under the Eyetamins by Optase label.
Differentiator
Problem solved
Functional benefit
Brands
- Eyetamins by Optase: Eye health supplements including Vision Support (formerly Actase Lutein ZA) and OmegaEye Advanced (formerly Actase OmegaEye Advanced). Acquired in October 2024 as part of Scope's expansion into eye supplement products.
- HYLO
- Hycosan
- OPTASE
Products and services
- HYLO-Forte Preservative-free lubricating eye drops containing 0.2% sodium hyaluronate, recommended for severe and persistent dry eye disease symptoms. Winner of 'Best Eye Care Product' at OTC & Retail Product Awards in 2022, 2023 and 2024.
- HYLO-Tear Preservative-free eye drops containing 0.1% sodium hyaluronate for mild to moderate dry eye symptoms and contact lens irritation.
- HYLO-Fresh Refreshing preservative-free eye drops containing 0.03% sodium hyaluronate and Euphrasia, formulated for red, itchy eyes and screen fatigue.
- HYLO-Dual Preservative-free eye drops containing sodium hyaluronate and Ectoin, providing relief from lipid deficient dry eye and Meibomian Gland Dysfunction (MGD).
- HYLO-Dual Intense Preservative-free eye drops containing 0.2% High Molecular Weight Hyaluronic Acid and 2% Ectoin, formulated for instant, long-lasting relief from intense dry eye symptoms.
- HYLO-Care Preservative-free eye drops containing 0.1% sodium hyaluronate and Dexpanthenol, recommended for patients with damage or injury to the surface of the eye.
- HYLO Night Soft and consistent eye ointment containing Vitamin A to soothe dry, itchy eyes while sleeping (formerly marketed as VitA-POS).
- Hycosan Original Preservative-free eye drops containing sodium hyaluronate that replenishes the tear film for dry eye symptom relief.
- Hycosan Extra Preservative-free eye drops recommended for severe and persistent dry eye disease symptoms.
- Hycosan Intense Preservative-free eye drops containing 0.2% Hyaluronic Acid and 2% Ectoin for intense hydrating relief and long-term protection of severe inflammatory dry eye symptoms.
- Hycosan Fresh Preservative-free eye drops for refreshing relief from red and itchy eyes.
- Hycosan Dual Preservative-free eye drops containing 0.05% sodium hyaluronate and 2% Ectoin for relief from lipid deficient dry eye and Meibomian Gland Dysfunction.
- Hycosan Plus Preservative-free eye drops containing 0.1% sodium hyaluronate and 2% Dexpanthenol to aid natural healing of damaged eye surface due to surgical procedures, eye injury or dry eyes.
- Hycosan Night Preservative-free eye ointment using light liquid paraffin and Vitamin A providing up to 6 hours of lubrication for night-time soothing of dry eyes.
- EvoTears Innovative water-free eye lubricant for the management of Evaporative Dry Eye and Meibomian Gland Dysfunction.
- Eyetamins Vision Support Advanced eye supplement (formerly Actase Lutein ZA) containing Lutein 10mg, Zeaxanthin 2mg, Astaxanthin 2mg, plus Vitamins C, E, D and Zinc to support healthy vision and eye health, recommended by ophthalmologists.
- Eyetamins OmegaEye Advanced High-strength, purified Omega-3 supplement (formerly Actase OmegaEye Advanced) with re-esterified triglyceride Omega-3 and Vitamin D3 to support everyday eye health and maintenance of normal vision.
- OPTASE Moist Heat Mask Moist heat therapy mask providing relief from dry eye, Blepharitis, MGD, chalazion and styes.
- OPTASE Tea Tree Oil Eyelid Wipes Gentle, preservative-free Tea Tree Oil-based eyelid wipes for daily hygiene and blepharitis management.
- OPTASE Cooling Mask Reusable mask with HydroCool Technology providing fast, cooling relief from puffy, irritated eyes and allergy symptoms.
Quantifiable outcome
- 91% of users would recommend Eyetamins Vision Support
- +1 more outcomes
Companies that use Scope
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Scope technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
Scope partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights5 records
Scope competitors and assessment
Company assessmentDirect peers
- Théa Pharmaceuticals: French family-owned ophthalmology specialist with a strong preservative-free dry eye portfolio (Thealoz Duo) directly competing against Scope's HYLO and Hycosan ranges across European pharmacies and opticians.
- Rayner: UK-based ophthalmic company with a portfolio spanning intraocular lenses, dry eye products (e.g. Cationorm) and ocular surgery devices — competing directly with Scope's preservative-free lubricants in the UK/Ireland market.
Broad incumbents
- Bausch + Lomb: Global ophthalmic goods incumbent offering competing lubricant eye drops (e.g. Artelac, Vidisic) and a broad eye-care portfolio; competes with Scope at retail across Ireland and the UK.
- Alcon: World's largest eye-care company with a wide range of artificial tears (e.g. Systane, Opti-Free family) that compete against Scope's preservative-free offerings in pharmacy and optician channels.
- AbbVie (Allergan Aesthetics/Eye Care): Markets the Refresh Tears line of lubricant eye drops as part of a broader eye-care franchise that overlaps with Scope's dry eye symptom-relief proposition.
- Santen Pharmaceutical: Japan-headquartered ophthalmology specialist with a European presence (including preservative-free dry eye products), competing for the same HCP recommendation channel as Scope.
Emerging players
- Nicox: France-based ophthalmology company focused on glaucoma and ocular surface diseases; commercial-stage products compete for the same optometrist/ophthalmologist recommendation channel as Scope.
- Novaliq: German specialty pharma developing water-free ophthalmic solutions (e.g. EvoTears/Vevye) for dry eye, competing technologically with Scope's preservative-free COMOD platform for the same severe-DED patients.
- Kala Bio: US clinical-stage ophthalmology company developing novel dry eye therapies; represents the prescription-drug competitive frontier that could erode Scope's OTC lubricant category over time.
Regional players
- AFT Pharmaceuticals: Australasia-headquartered specialty pharma with growing European presence in eye care and OTC ophthalmics — overlapping with Scope on preservative-free lubricants and HCP-led distribution.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Scope social profiles
Digital presenceScope financial estimates
Financial estimateRevenue estimate
Valuation estimate
Scope leadership team
Management profileNumber of profiles
Profiles2 records
Scope subsidiaries and ownership
Company hierarchySubsidiaries1 record
Scope funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Scope M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Scope
What does Scope do?
Scope Eyecare (Scope Ophthalmics Ltd) distributes a portfolio of preservative-free eye care products including lubricant eye drops under the HYLO and Hycosan ranges, eyelid hygiene and thermal therapy products under the OPTASE brand, the EvoTears water-free lubricant, and the Eyetamins line of eye health nutritional supplements. The products target dry eye disease, meibomian gland dysfunction (MGD), blepharitis, ocular allergies, and macular support, delivered across Ireland and the UK through the company's own e-commerce storefront, pharmacies, and opticians.
Is Scope a public or private company?
Scope is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Scope founded?
Scope was founded in 2009. It employs 51 to 100 people.
Where is Scope based?
Scope is headquartered in Dublin, Ireland, in the Europe region.
How does Scope make money?
Two revenue lines are on record. Eye Drop Product Sales are the primary driver. The others are eye Supplement Sales.
Who are Scope's main competitors?
Direct peers on record are Théa Pharmaceuticals and Rayner. Broad incumbents are Bausch + Lomb, Alcon, AbbVie (Allergan Aesthetics/Eye Care) and Santen Pharmaceutical. Emerging players are Nicox, Novaliq and Kala Bio. AFT Pharmaceuticals is listed as a regional player.
Does Scope have an API?
No public API is recorded for Scope.
What industry is Scope in?
Scope's product category is Ophthalmic Eye Care Products. Its primary akta.pro industry code is HLAHAIAL, Ocular Drug Delivery Devices (Eye Droppers/Inserts). Its NAICS code is 45613 and its SIC code is 3851.